Keerthi Sripathi

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

UA Fort Smith

Also affiliated: Mercy Medical Center (2025); Mercy Hospital (2025); CHI Health Mercy Council Bluffs (2025); Icahn School of Medicine at Mount Sinai (2025)

Unknown Researcher

1 h-index 5 pubs 1 cited

Research Areas

OverviewAI-generated summary

Keerthi Sripathi's research focuses on the analysis of clinical trial data and patient outcomes across various hematological and cardiovascular conditions. Sripathi has co-authored publications examining survival rates in transplant-ineligible multiple myeloma patients undergoing different quadruple and triple therapies. Other work investigates unique presentations of diseases, including cold agglutinin disease in myeloid malignancy, myelofibrosis mimicking hepatic dysfunction, and primary pulmonary follicular lymphoma. Additionally, Sripathi has contributed to umbrella meta-analyses on outcomes of different devices in patients with atrial fibrillation.

Sripathi collaborates with Aswanth Reddy and Maha Zafar at the University of Arkansas – Fort Smith, with whom they have co-authored multiple publications. The researcher's work leverages meta-analysis and retrospective study designs to synthesize existing clinical data and inform understanding of disease progression and treatment efficacy.

Metrics

h-index: 1
Publications: 5
Citations: 1

Selected Publications

AML-463: Unraveling a Unique Presentation of Cold Agglutinin Disease in Myeloid Malignancy (2025)

Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex
Survival Following Quadruplet and Triple Therapy in Transplant in-Eligible Multiple Myeloma - a Meta-Analysis of Recent Clinical Trials (2024)

Blood 1 citation DOI OpenAlex